These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27174314)

  • 1. Jojoba Oil Soft Colloidal Nanocarrier of a Synthetic Retinoid: Preparation, Characterization and Clinical Efficacy in Psoriatic Patients.
    Nasr M; Abdel-Hamid S; Moftah NH; Fadel M; Alyoussef AA
    Curr Drug Deliv; 2017; 14(3):426-432. PubMed ID: 27174314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleuropein as a novel topical antipsoriatic nutraceutical: formulation in microemulsion nanocarrier and exploratory clinical appraisal.
    El-Gogary RI; Ragai MH; Moftah N; Nasr M
    Expert Opin Drug Deliv; 2021 Oct; 18(10):1523-1532. PubMed ID: 34010073
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel antipsoriatic fluidized spanlastic nanovesicles: In vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy.
    Elmowafy E; El-Gogary RI; Ragai MH; Nasr M
    Int J Pharm; 2019 Sep; 568():118556. PubMed ID: 31348982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid membrane tubulation using ceramide doping "Cerosomes": Characterization and clinical application in psoriasis treatment.
    Abdelgawad R; Nasr M; Moftah NH; Hamza MY
    Eur J Pharm Sci; 2017 Apr; 101():258-268. PubMed ID: 28232140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-selective retinoids for psoriasis: focus on tazarotene.
    Weindl G; Roeder A; Schäfer-Korting M; Schaller M; Korting HC
    Am J Clin Dermatol; 2006; 7(2):85-97. PubMed ID: 16605289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
    Sander P; Happe M; Stücker M; Hermes N; Hoffmann K; Altmeyer P
    Hautarzt; 1999 Oct; 50(10):723-7. PubMed ID: 10550358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methotrexate soft nanocarrier/fractional erbium YAG laser combination for clinical treatment of plaque psoriasis.
    Ramez SA; Soliman MM; Fadel M; Nour El-Deen F; Nasr M; Youness ER; Aboel-Fadl DM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):996-1002. PubMed ID: 29448838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical safety of tazarotene in the treatment of plaque psoriasis.
    Marks R
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S25-32. PubMed ID: 9270553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tazarotene gel: efficacy and safety in plaque psoriasis.
    Weinstein GD
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S33-8. PubMed ID: 9270554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
    Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP
    Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
    Tang-Liu DD; Matsumoto RM; Usansky JI
    Clin Pharmacokinet; 1999 Oct; 37(4):273-87. PubMed ID: 10554045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia).
    Ali J; Akhtar N; Sultana Y; Baboota S; Ahuja A
    Methods Find Exp Clin Pharmacol; 2008 May; 30(4):277-85. PubMed ID: 18773122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short contact therapy with tazarotene in psoriasis vulgaris.
    Veraldi S; Caputo R; Pacifico A; Peris K; Soda R; Chimenti S
    Dermatology; 2006; 212(3):235-7. PubMed ID: 16549919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling.
    Nasr M; Abdel-Hamid S
    Drug Dev Ind Pharm; 2016; 42(4):636-43. PubMed ID: 26133080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks.
    Weinstein GD; Koo JY; Krueger GG; Lebwohl MG; Lowe NJ; Menter MA; Lew-Kaya DA; Sefton J; Gibson JR; Walker PS;
    J Am Acad Dermatol; 2003 May; 48(5):760-7. PubMed ID: 12734506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid therapy for psoriasis.
    Yamauchi PS; Rizk D; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):467-76, x. PubMed ID: 15450342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
    Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
    Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of limonene-based syringic acid nanoemulsion: Enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy.
    Assalem N; Abd-Allah H; Ragaie MH; Ahmed SS; Elmowafy E
    Int J Pharm; 2024 Jul; 660():124376. PubMed ID: 38914355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.